XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Research and development $ 627 $ 469 $ 1,269 $ 929
General and administrative 552 654 1,194 1,287
Total operating expenses 1,179 1,123 2,463 2,216
Operating Loss 1,179 1,123 2,463 2,216
Finance Income (Expenses), net (3) 4 (1) 4
Net Loss 1,176 1,127 2,462 2,220
Other comprehensive income:        
Foreign currency translation adjustment (6) (30) (11) (37)
Comprehensive loss for the period $ 1,170 $ (1,097) $ 2,451 $ (2,183)
Basic net loss per common stock $ (0.09) $ (0.07) $ (0.18) $ (0.14)
Diluted net loss per common stock $ (0.09) $ (0.07) $ (0.18) $ (0.14)
Weighted average number of common stock outstanding used in computing basic net loss per share 21,561,473 15,473,813 18,532,553 15,465,692
Weighted average number of common stock outstanding used in computing diluted net loss per share 21,561,473 15,473,813 18,532,553 15,465,692